Dynamic network biomarker indicates pulmonary metastasis at the tipping point of hepatocellular carcinoma
Biomarkers of the tipping point before metastasis in hepatocellular carcinoma (HCC) could help stratify patient treatment. Here, the authors study dynamic network biomarkers to identify CALM3 as a potential suppressor of metastasis, the level of which can predict overall survival and relapse-free su...
Guardado en:
Autores principales: | Biwei Yang, Meiyi Li, Wenqing Tang, Weixin Liu, Si Zhang, Luonan Chen, Jinglin Xia |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d31dcd972fe9482cbbe9f9714a145d99 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification and Validation of TYMS as a Potential Biomarker for Risk of Metastasis Development in Hepatocellular Carcinoma
por: Shuai Li, et al.
Publicado: (2021) -
Computational Identification of Immune- and Ferroptosis-Related LncRNA Signature for Prognosis of Hepatocellular Carcinoma
por: Anmin Huang, et al.
Publicado: (2021) -
Isolated Intracardiac Metastasis: The First Sign of Hepatocellular Carcinoma
por: Anusca Paixão, et al.
Publicado: (2021) -
Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility
por: Ferrín G, et al.
Publicado: (2015) -
The Efficacy of Radiotherapy in the Treatment of Hepatocellular Carcinoma with Distant Organ Metastasis
por: Lei Chen, et al.
Publicado: (2021)